SCA Pharmaceuticals recalls Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, C…
- Recall date
- April 10, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0555-2023
- FDA classification
- Class III
- Brand / firm
- SCA Pharmaceuticals
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Subpotent Drug: Out of specification results for low potency was obtained.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44
Get recall alerts
Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals